| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The neural mechanisms of propofol-induced central respiratory depression remain poorly understood. In the present study, we studied these mechanisms and the involvement of -aminobutyric acid (GABA)A receptors in propofol-induced central respiratory depression. The brainstem and the cervical spinal cord of 1- to 4-day-old rats were isolated, and preparations were maintained in vitro with oxygenated artificial cerebrospinal fluid. Rhythmic inspiratory burst activity was recorded from the C4 spinal ventral root. The activity of respiratory neurons in the ventrolateral medulla was recorded using a perforated patch-clamp technique. We found that bath-applied propofol decreased C4 inspiratory burst rate, which could be reversed by the administration of a GABAA antagonist, bicuculline. Propofol caused resting membrane potentials to hyperpolarize and suppressed the firing of action potentials in preinspiratory and expiratory neurons. In contrast, propofol had little effect on resting membrane potentials and action potential firing in inspiratory neurons. Our findings suggest that the depressive effects of propofol are, at least in part, mediated by the agonistic action of propofol on GABAA receptors. It is likely that the GABAA receptor-mediated hyperpolarization of preinspiratory neurons serves as the neuronal basis of propofol-induced respiratory depression in the newborn rat.
IMPLICATIONS: We analyzed the effects of propofol on medullary respiratory neurons in brainstem-spinal cord preparations from newborn rats in vitro using a perforated patch-clamp technique. Our findings suggest that the
There have been several experimental studies on the patterns and mechanisms of propofol-induced respiratory depression in humans (13) and in animals in vivo (4,5). However, most of these studies have focused only on the dose-response relationship. Based on these reports, it has been suggested that propofol induces respiratory depression by inhibiting the central inspiratory drive. However, the precise neural mechanisms of propofol-induced respiratory depression remain poorly understood. There are no reported studies on brainstem neuronal responses to propofol, indicating the need for experimental measurements of respiratory neuron activity in vitro to elucidate the central respiratory effects of propofol at the cellular level. Brainstem-spinal cord preparations from the newborn rat provide an established model for the investigation of the mammalian respiratory neuronal network (6,7). This model maintains spontaneous respiratory activity that can be recorded from the C4 ventral root of the spinal cord, enabling the study of the central mechanisms of respiratory control free from the influence of supramedullary and peripheral afferent inputs (8). The rat brainstem model is also advantageous for pharmacological studies (912) because it is possible to superfuse preparations with drugs at controlled concentrations and to observe the pharmacological effects in an anesthetic- and muscle relaxant-free condition.
The present study was conducted to investigate (a) the response of medullary respiratory neurons to propofol, including its effects on membrane properties, and (b) the role of
This study was approved by the Keio University Laboratory Animal Care and Use Committee. All experiments in the study (Experiments 1, 2, and 3) were conducted using isolated brainstem-spinal cord preparations. The surgical procedure used to make these preparations has been described in detail elsewhere (13). Briefly, brainstems (including spinal cords) of 1- to 4-day-old Wistar rats of either sex were isolated under deep ether anesthesia. The brainstem was transected at the level of the roots of cranial nerve VI. The preparation consisted of the isolated brainstem and spinal cord extending from the rostral medulla oblongata to the spinal cord segment C8. Each preparation was placed ventral side up in a recording chamber (volume, 2 mL) and superfused continuously at a flow rate of 7 mL/min with the following modified Krebs solution (in mM): NaCl 124, KCl 5.0, KH2PO4 1.2, CaCl2 2.4, MgSO4 1.3, NaHCO3 26, glucose 30, equilibrated with 95% O25% CO2. The temperature was maintained at 25°C26°C, and the superfusate pH value was 7.4. In Experiment 2, we used a chamber, partitioned at the spinomedullary junction to permit the selective application of drugs. The partition was made using two thin polyvinyl chloride plates placed parallel to each other with woven nylon packed between them. Each partitioned section had a capacity of 1 mL and was superfused continuously at a flow rate of 4 mL/min. Propofol was obtained from Tokyo Kasei Kogyo (Tokyo, Japan). Stock solutions of 1 M of propofol were prepared in dimethylsulfoxide (Wako Pure Chemical, Osaka, Japan) and diluted with the control superfusate to give final propofol concentrations of 5100 µM. The final concentration of dimethylsulfoxide was <0.01% (vol/vol). Bicuculline was obtained from Sigma (St. Louis, MO). After saturation at 95% O25% CO2, the pH value of the solutions was adjusted to 7.4 using HCl or NaHCO3. Rhythmic inspiratory burst activity was continuously recorded from the C4 ventral root (which contains the phrenic nerve fibers) using a glass suction electrode (9,13,14). The C4 electrical signals were bandpass-filtered (5010,000 Hz), amplified, halfwave-rectified, and integrated with a time constant of 100 ms.
In Experiment 3, neuronal activities in the rostral ventrolateral medulla were recorded intracellularly using a perforated patch-clamp configuration. The protocol was as detailed in previous reports (13,15). Briefly, a glass micropipette (GC100-TF-10; Clark; Reading, United Kingdom) was pulled with a horizontal puller to a tip size of approximately 2 µm. Electrode resistance ranged from 10 to 14 M In Experiments 1 and 2, the preparations were superfused with the control solution in the recording chamber for at least 30 min before recording to stabilize C4 activity; in Experiment 3, the preparations were superfused with the control solution for approximately 10 min before recording. Preparations in which respiratory output from C4 roots was unstable were excluded.
Experiment 1
Experiment 2
Experiment 3 Medullary neurons were categorized into four groups according to their firing patterns: preinspiratory, inspiratory, expiratory, and nonrespiratory neurons (13,14,16). Neurons that showed burst activity during preinspiratory and postinspiratory phases were defined as preinspiratory. Inspiratory neurons were identified as those discharging bursts during the C4 burst activity phase. Expiratory neurons are characterized by hyperpolarization or absence of firing synchronous with C4 burst firing. Neurons that exhibited tonic patterns and showed no respiratory modulation were categorized as nonrespiratory. Data are presented as mean and SD for all preparations in the study groups. C4 inspiratory burst rates were calculated from the total number of bursts within a 5-min period before switching the superfusate in Experiments 1 and 2. Intraburst firing frequencies of preinspiratory and expiratory neurons are represented by the mean firing frequency during the expiratory phase, and intraburst firing frequencies of inspiratory neurons are represented by the mean firing frequency during the inspiratory phase. The mean and SD of the intraburst firing frequencies, resting membrane potentials, and C4 inspiratory burst rates were calculated based on recordings from 5 respiratory cycles in Experiment 3. Apnea was defined as the absence of C4 inspiratory burst activity for 60 s or longer. Changes in C4 inspiratory burst rates were compared by using one-way analysis of variance, followed by either Dunnett test (in Experiment 1) or the Student-Newman-Keuls test (in Experiment 2). In Experiment 3, a paired t-test was used to compare resting membrane potentials, intraburst firing frequencies, and C4 inspiratory burst rates before and during drug administration. P < 0.05 was considered statistically significant.
Experiment 1 Representative tracings of integrated C4 activity ( C4) before and during superfusion with propofol-containing solutions are shown in Figure 1. There were no significant differences among the four groups in the baseline values of C4 inspiratory burst rates (Fig. 2A). Preparations in the control group maintained the baseline C4 inspiratory burst rate throughout the entire 120-min recording period. C4 inspiratory burst rates decreased over time in the propofol groups. Larger concentrations of propofol tended to produce greater and steeper decreases in C4 inspiratory burst rate, although this effect was not linearly dose-dependent. C4 inspiratory burst rates after 30 min of superfusion with 5, 10, or 20 µM of propofol were significantly less than in the control group (P < 0.05). The incidence of apnea increased in a concentration- and time-dependent manner. After 90 min of superfusion with propofol, the percentages of preparations in which apnea had occurred were as follows: 5 µM, 0%; 10 µM, 40%; and 20 µM, 80%.
Experiment 2 Bicuculline, a GABAA antagonist, induced the complete recovery of C4 inspiratory burst rates that had been decreased by propofol (Fig. 2B). In the same preparations, C4 inspiratory burst rates decreased once again after bicuculline washout.
Experiment 3
Our major findings are that propofol exerts a depressive effect on neuronal output in the medullary respiratory center and that this depression can be reversed by a GABAA receptor antagonist. Propofol inhibits spontaneous burst activity in medullary preinspiratory and expiratory neurons, but not in inspiratory neurons. In the present study, we used the in vitro brainstem-spinal cord preparation. This preparation enables analyzing effects of various drugs on central respiratory control. It is also especially suitable for perforated patch recording of identified respiratory neurons in an anesthetic- and muscle relaxant-free condition (7). Because this preparation lacks blood circulation, it is also possible to exclude the influences of the changes of cardiovascular function when analyzing drug effects on the respiratory neuronal network. However, to maintain the viability of the preparation that has limited oxygen supply and to obtain stable respiratory rhythm, a lowered temperature (approximately 25°C26°C) that reduces the oxygen demand is the most suitable for the preparation (17). Also, only small newborn animals (e.g., rat and mouse, age 05 days old) can be successfully used for this preparation because newborn animals can more easily survive than adult animals, even when oxygen supply is reduced and because oxygen is more readily supplied to respiratory neurons by diffusion through a shorter diffusion distance in a smaller preparation (7,17). Although it is conceivable that substantial changes in respiratory network organization or membrane properties occur within the first few weeks after birth, there are already the basic synaptic connections among respiratory neurons, even in newborn rats (18,19). The baseline value of inspiratory burst rates observed in the in vitro preparation is less than that seen in intact newborn rats. This reduction is caused by the experimental conditions, i.e., deafferentation and the low temperature of the preparation (9,20). Nonetheless, this type of preparation has been extensively used to study the effects of neurotransmitters, neuromodulators, and other neuroactive substances on the respiratory rhythm-generating network with good results (6,7,912,16). In the present study, we used propofol at concentrations of 5100 µM. Blood or plasma concentrations of propofol in clinical situations are also often in the range of 1030 µM (26 µg/mL) (21) and up to 110 µM (20 µg/mL) (22). However, we consider that propofol concentrations of the superfusate of in vitro experiments and those of blood or plasma in humans need not precisely coincide because various factors, such as species (rats and humans) and delivery routes for propofol to target neurons, are quite different between an in vitro experimental condition and a clinical situation. There has been a study to measure the propofol concentration in cerebrospinal fluid in humans (approximately 0.2 µM) (23), and it is much smaller than that in human plasma and in the superfusate in our experiments. We consider that this is because only a part of IV propofol moved to cerebrospinal fluid and was diluted in the in vivo situation. However, propofol concentration in the brain tissue of the in vivo rat is approximately 80200 µM when an anesthetic dose of propofol was given IV (24). Indeed, in pharmacological experiments using in vitro brain-slice preparations, propofol has been typically applied at concentrations up to several hundred micromoles per liter (25). Therefore, the propofol concentration in the superfusate in our study is considered to be appropriate. The concentration of propofol in Experiment 3 was larger than that in Experiments 1 and 2. This was because it is advantageous to complete each analysis in a short time to obtain high-quality intracellular neuronal recordings and because when the concentration of propofol is larger, the effect appears more quickly. In Experiment 3, the responses of C4 inspiratory burst activity to propofol were essentially similar to those in Experiments 1 and 2 and characterized by decreases in inspiratory burst rates with constant integrated C4 amplitudes (Figs. 13). Nonetheless, extreme caution is required to extrapolate the results obtained in in vitro experiments to an in vivo situation, and our results must be confirmed in in vivo animal experiments. In the present study, propofol, when selectively applied to the medulla, induced a decrease in C4 inspiratory burst rate. The inspiratory burst rate in brainstem-spinal cord preparations from newborn rat is widely considered to provide a reliable physiological index of central respiratory output (9,11,12). IV propofol decreases ventilation mainly by reducing tidal volume (13). Similarly, in an in vivo rabbit experiment (5), the amplitude of integrated phrenic nerve activity, which represents tidal volume (26), was reduced after the administration of propofol. However, this reduction in the amplitude of C4 activity in the in vitro brainstem-spinal cord preparation is less informative because it can be affected by C4 inspiratory burst rates (6,7). Indeed, more frequent inspiratory burst rates can diminish C4 burst amplitude because of the refractory periods of some of medullary neurons (6,7). In summary, the propofol-induced decrease in C4 inspiratory burst rate indicates that propofol reduces the output of the medullary respiratory neuronal network irrespective of C4 amplitude. Respiratory neurons in the ventrolateral medulla of the isolated brainstem-spinal cord preparation form a neuronal network that is responsible for central respiratory control. It has been suggested that the excitatory network of preinspiratory neurons in the rostral ventrolateral medulla constitutes the respiratory rhythm generator and that inspiratory neurons in the rostral and caudal ventral medulla constitute the inspiratory pattern generator (6,7). In this model, the respiratory rhythm generator periodically triggers the inspiratory pattern generator to produce inspiratory burst activity. The output of the inspiratory pattern generator drives motor neurons, such as the phrenic or cranial nerves (6,7). Therefore, the burst rates of inspiratory neurons and C4 are thought to be dependent on those of preinspiratory neurons (14,16). The propofol-induced decrease in burst rates of inspiratory neurons does not seem to be the result of direct inhibition because we observed neither a significant change in resting membrane potentials nor obvious arrest of burst activity in these neurons, even at a large concentration of propofol. Our results suggest that propofol primarily suppresses preinspiratory neurons, resulting in the indirect suppression of inspiratory neurons and the C4. However, the number of intracellularly recorded respiratory neurons was small, and further study will be required to confirm the effect of propofol on respiratory neurons. Propofol facilitates inhibitory synaptic transmission by promoting the function of the ß1 subunit of the GABAA receptor through the activation of chloride channels (27,28). Propofol anesthesia in adult mice is potentiated by a GABAA agonist muscimol and reversed by bicuculline (29). Bath-applied GABA (16,30) and muscimol (30) also reduce the burst rate of preinspiratory neurons, and bicuculline blocks the muscimol-induced respiratory arrest (30) in isolated brainstem-spinal cord preparations from the newborn rat. Bicuculline also blocks the hyperpolarization evoked by GABA and muscimol in preinspiratory neurons (30). In the present study, we found that propofol reduced C4 inspiratory burst rate, and this effect was blocked by bicuculline. This prompts us to suggest that the propofol-induced decrease in C4 inspiratory burst rate is, at least partly, caused by the activation of GABAA receptors. Preinspiratory neurons (16,30) and expiratory neurons (31) have GABAA receptor-mediated inhibitory postsynaptic potentials. In the present study, propofol induced hyperpolarization of the resting membrane potentials and arrest of burst activity in preinspiratory and expiratory neurons. It is probable that propofol-induced hyperpolarization modulates the excitability of preinspiratory and expiratory neurons through the activation of GABAA receptors. Further study is required to identify the type of receptor that is involved in propofol-induced hyperpolarization of respiratory neurons. In summary, we suggest that propofol suppresses the activity of preinspiratory and expiratory neurons, but not that of inspiratory neurons. The propofol-induced decrease of respiratory output is considered to be mediated through the inhibition of preinspiratory neurons. Our findings also suggest that GABAA receptor activation is involved in propofol-induced respiratory depression.
Supported, in part, by Keio University Grant-in-Aid, Tokyo, Japan; Keio University Medical Science Fund, Tokyo, Japan; Keio Gijuku Academic Development Funds, Tokyo, Japan; Grant-in-Aid from the Japanese Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan; and Research Grant for Specific Diseases from the Japanese Ministry of Health, Labour and Welfare. We express our appreciation to Dr. A. Kawai for his advice on experimental techniques.
Presented, in part, as an abstract at the 2001 annual meeting of the American Society of Anesthesiologists, New Orleans, LA, October 2001, and at the 49th annual meeting of the Japanese Society of Anesthesiologists, Fukuoka, Japan, April 2002.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|